Tuesday, Aug 18, 2026 · SEC filings
What the smart money revealed on Aug 18
945 insider filings came in. We hid 135 planned (10b5-1) sellers and 685 people whose filings were routine, like grants and tax withholding.
4 insiders at Verrica Pharmaceuticals (VRCA) bought $211K of stock
Roles: CEO and President, CMO, COO, Interim CFO, Director. Several insiders buying in the same few days is rare.
Aura Minerals (AUGO) Director Mauad Sousa bought $868K
11,000 shares on the open market. Not a grant or an option exercise.
TechnipFMC (FTI) Director Eric Mullins bought $500K
6,365 shares on the open market. Not a grant or an option exercise.
Ascendis Pharma A/S (ASND) Director Jean Bienaime bought $493K
2,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 6 checked quarters beat the typical stock 6 months later.
Ensysce Biosciences (ENSC) Director Bob Gower bought $444K
908,614 shares on the open market. Not a grant or an option exercise.
VY Capital Management filed its holdings: 6 stocks
Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.
Rakuten Investment Management filed its holdings: 467 stocks
Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.
Chevron (CVX) Chairman and CEO Michael Wirth sold $63.6M
Not marked as a planned 10b5-1 sale. Sold 92% of the shares they held directly. Still holds 26,308 shares.
MaxLinear (MXL) Chairman Kishore Seendripu sold $50.4M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Venture Global (VG) Senior VP Fory Musser sold $6.58M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
13F season
Holdings as of Jun 30, 2026 are due Aug 14
8,899 funds have filed so far. 8,900 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Aug 18.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.